Botulinum toxin as a novel therapeutic approach for auriculotemporal neuralgia

• Type: Article in International Scientific Journal
• Date: 2021

Authors

Pinto, MJ (Author) FMUP; Guerrero, AL (Author) Other; Costa, A (Author) Other

Journal

Title: Headache

Vol. 61

Pages: 392-395

ISSN: 0017-8748

Publisher: Wiley-Blackwell

Indexing

ISI Web of Knowledge - 2 Citations

Scopus - 2 Citations

Other information

Authenticus ID: P-00T-ABR

DOI: 10.1111/head.14043

Abstract (EN): Objectives/Background: Auriculotemporal neuralgia is a rare headache disorder. Anesthetic nerve blockade seems to be effective in most cases; however, literature is scarce about the management of refractory cases. Methods: Case report. Results: We report a 44-year-old woman with migraine without aura presented with moderate-to-severe right temporoparietal headache. The pain was refractory to multiple pharmacological strategies, including intravenous analgesia. A more throughout examination lead to the diagnosis of auriculotemporal neuralgia and anesthetic nerve blocks were performed. Due to early pain recrudescence, botulinum toxin (BoNT) was tried with better and longstanding pain control. Conclusion: BoNT may be a useful treatment option in refractory auriculotemporal neuralgia. The best approach is yet to be established; however, the "follow-the-pain" protocol may be a reasonable option.

Language: English

Type (Professor's evaluation): Scientific

No. of pages: 4